Aethlon Medical, Inc. (OTC:AEMD) has been gaining momentum after it published its last quarterly report.
The company reported $958 thousand in revenue and based on that it later issued an 8-K form to announce it was no longer considered a development-stage company.
The news was stimulating enough to provoke traders to tilt the demand supply balance and push the stock price up by 100%.
In a matter of two trading days, AEMD jumped up from $0.07 to $0.14 on a heavy trading volume. The number of shares which changed hands on the last trading 
session exceeded 1.7 million, which is one of the highest in the last 52 weeks.
FINRA showed that 541 thousand shares were exchanged in short transactions yesterday. This makes 31% of the whole trading volume.
The share price of AEMD stock is now close to a new 52-week which can give a lot of opportunities for speculation in the coming days.
